LOW vs VVOS · P/E 18, rev $86.29B vs rev $15.0M
Lowe's Companies Inc (LOW) versus Vivos Therapeutics Inc (VVOS) — a side-by-side from cached financials, not a winner call.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Vivos Therapeutics Inc (VVOS) is a medical devices company listed on NASDAQ.
Latest reported LOW revenue for 2026-01-30 was $86.29B. Net income was $6.65B. Revenue was up 3.1% from 2025-01-31 to 2026-01-30. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
Latest reported VVOS revenue for 2024-12-31 was $15.0M. Net income was -$11.1M. Revenue was up 8.9% from 2023-12-31 to 2024-12-31. VVOS currently screens at market cap $7.1M.
LOW currently screens at market cap $121.89B and trailing P/E 18.4. VVOS currently screens at market cap $7.1M.
Not investment advice. Open the LOW and VVOS stock pages for the full models.
Not investment advice.